Skip to Content
 

News: Leukemia

Cardiac toxicity risk factors identified with relapsed multiple myeloma therapy

Saturday, June 29th, 2019

More than half of patients with relapsed multiple myeloma treated with carfilzomib experienced cardiac issues during treatment, according to a multi-institutional study published June 12 in the Journal of Clinical Oncology.

Teamwork key to treating patient’s rare blood cancer

Saturday, December 1st, 2018

Patient Joe Lofaro credits the teamwork of Nishitha Reddy, MBBS, MSCI, and other clinicians at VUMC for diagnosing him with the rare blood cancer Erdheim-Chester disease.

Cancer Center among best in nation for stem cell transplant survival

Monday, November 5th, 2018

Vanderbilt-Ingram Cancer Center’s Stem Cell Transplant ranks among the best in the nation for donor stem cell transplant survival rates among large centers, according to an annual report.

Using light to fight GVHD

Tuesday, September 4th, 2018

Vanderbilt investigators have conducted a prospective multicenter study on how extracorporeal photopheresis works in treating chronic graft-versus-host disease (cGVHD) — a complication of bone marrow or stem cell transplant that occurs when donor cells attack the recipient.

Connecting an asthma gene to leukemia

Friday, August 3rd, 2018

A receptor previously implicated in asthma may also play roles in other allergic diseases and in leukemia, Vanderbilt researchers have discovered.

Young named chief medical officer of American Red Cross

Thursday, January 4th, 2018

Vanderbilt’s Pampee Young, MD, PhD, has been named chief medical officer of the American Red Cross.

Vanderbilt to host symposium on bone marrow disorders

Sunday, September 17th, 2017

Vanderbilt University Medical Center (VUMC) clinicians will host an educational symposium on bone marrow disorders, including bone marrow failure, acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), on Friday, Oct. 13, from 11:30 a.m. – 6 p.m. at the Omni Nashville Hotel, 250 5th Ave. South.

HDAC3 role in B-cell development

Monday, August 7th, 2017

Histone deacetylases (HDACs) are enzymes that modulate gene expression and have important roles in development and disease. HDAC inhibitors are active against lymphoma, and understanding the roles of specific HDACs is important for further therapeutic development. Scott Hiebert, Ph.D., and colleagues used a mouse model to explore the role of HDAC3 in the early development […]

Restore T cells to fight leukemia

Thursday, September 15th, 2016

Acute and chronic B cell leukemia can promote T cell “exhaustion,” which contributes to increased susceptibility to infection and mortality. The treatment-independent mechanisms by which leukemia promotes T cell dysfunction are poorly understood, however. Since metabolic pathways must be tightly regulated to allow normal T cell proliferation and function, Jeffrey Rathmell, Ph.D., Peter Siska, M.D., […]

Medical staff, theater join forces to help cancer patient see ‘Star Wars’

Thursday, January 21st, 2016

A Vanderbilt patient who has battled leukemia for nearly five years was granted a private screening of “Star Wars: The Force Awakens,” thanks to her medical providers and a local movie theater. Like millions of fans worldwide, Natalie Seale, 22, was excited to see the long-anticipated film, but she is unable to be in large […]

Next Page »